TRADING UPDATES: IntelliAM grows revenue 58%; Solid State profit jumps
4th Nov 2025 17:42
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
RUA Life Sciences PLC - holding company of multiple medical device businesses - Pretax loss narrows to just GBP10,000 in the financial year to March 31 from GBP2.0 million a year prior. Revenue jumps to GBP4.1 million from GBP2.2 million although administrative expenses rise to GBP4.2 million from GBP3.8 million. All revenue-generating business units contribute to the growth, with Biomaterials growing 18% from GBP496,000 to GBP587,000, and the Medical Device and Components business more than doubling to GBP3.5 million from GBP1.7 million. Gross margin fell from 81% to 77% partly due to the Biomaterials business, on which gross margins remain at over 94%, being diluted by the faster-growing contract manufacturing business. "Compared to other industries, growing a medical device business can be frustratingly slow due to the necessary regulatory requirements; however, the past 12 months have been exceptional, with a doubling in the scale of the business. The new business opportunities being pursued are equally exciting and, if successful, will add further to the growing high-quality revenues," says Chair Geoff Berg. Read More
(Alliance News) - RUA Life Sciences PLC on Monday celebrates its newly acquired manufacturer of a number of long-term implantable devices swinging to a profit in 2024. Read More
(Alliance News) - RUA Life Sciences PLC on Wednesday celebrated a return to profit as the company cut costs and grew revenue in the first-half of its financial year. Read More
(Alliance News) - RUA Life Sciences PLC on Monday said that it has bought the entirety of Analytic Biosurgical Solutions SAS, a manufacturer of a number of long-term implantable devices. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - RUA Life Sciences PLC shares rose on Wednesday, after it reported that its annual loss narrowed, and it is trading in line with expectations. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - RUA Life Sciences PLC on Friday said the first half of its financial year was hit by operational issues, although second-half performance "fully compensated" this and that revenue is set to meet expectations. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - RUA Life Sciences PLC on Monday said loss widened in the first half, tracking falling revenue, although it stressed it aims to turn profitable in the shorter-term. Read More
(Alliance New) - RUA Life Sciences PLC on Friday said it has raised GBP4.4 million through a placing, subscription and retail offer. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More
(Alliance News) - RUA Life Sciences PLC on Friday announced the results of the equity raise it announced after the London market close on Thursday, taking in GBP4.0 million. Read More
RUA Life Sciences PLC - Glasgow-based medical technology holding company - Intends to conduct placing of a minimum of 36.4 million new shares at a price of 11 pence each to raise a minimum of GBP4.0 million. Also plans a further GBP80,00 raise via subscription of 727,272 new shares at the issue price from certain directors. Also plans a separate retail offer of up to 6.8 million shares at the issue price to raise a further GBP750,000. Expects to used net proceeds to strengthen its balance sheet to aid the commercialisation phase of its research & development projects within its vascular graft and HV leaflet composite; to accelerate growth within contract manufacturing; and to enable the company to demonstrate value across the portfolio. Says completion of the fundraising is conditional on shareholder approval at a general meeting on December 18. Read More
(Alliance News) - Stock prices in London were down midday on Friday, in a quiet day of trade as the Thanksgiving holiday saw global markets "hit the snooze button." Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More
(Alliance News) - RUA Life Sciences PLC on Friday said that it expects revenue to fall in the first half, after seeing contract manufacture sales decrease during the period. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More